Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival

The effect of thrombolysis in acute myocardial infarction on infarct size, left ventricular function, clinical course and patient survival was studied in a randomized trial comparing thrombolysis (269 patients) with conventional treatment (264 control patients). All 533 patients were admitted to the coronary care unit within 4 hours after the onset of symptoms related to the infarction. Baseline characteristics were similar in both groups. Informed consent was requested only of patients allocated to thrombolysis; no angiography was performed in 35. The infarct-related artery was patent in 65 patients and occluded in 169. Recanalization was achieved in 133 patients. The median time to angiographic documentation of vessel patency was 200 minutes after the onset of symptoms. The clinical course in the coronary care unit was more favorable after thrombolysis. Infarct size, estimated from myocardial enzyme release, was 30% lower after thrombolysis. In patients admitted within 1 hour after the onset of symptoms the reduction of infarct size was 51%, in those admitted between 1 and 2 hours it was 31% and in those admitted later than 2 hours it was 13%. Left ventricular function measured by radionuclide angiography before hospital discharge was better after thrombolysis (ejection fraction 48 +/- 15%) than in control patients (44 +/- 15%). Similar improvement was observed in patients with a first infarct only (thrombolysis 50 +/- 14%, control subjects 46 +/- 15%), in patients with anterior infarction (thrombolysis 44 +/- 16%, control subjects 35 +/- 14%) and in those with inferior infarction (thrombolysis 52 +/- 12%, control subjects 49 +/- 12%). Similar results were obtained by contrast angiography. Mortality was lower after thrombolysis. After 28 days 16 patients allocated to thrombolysis and 31 control patients had died. One year survival rates were 91 and 84%, respectively. On the other hand, nonfatal reinfarction occurred more frequently after thrombolysis (36 patients) than in control subjects (16 patients). Early thrombolysis by intracoronary streptokinase leads to a smaller infarct size estimated by enzyme release, preserves left ventricular function at the second week and leads to improved 1 year survival.

This article has been cited by other articles:

				M. D. Sullivan, P. S. Ciechanowski, J. E. Russo, L. A. Soine, K. Jordan-Keith, H. H. Ting, and J. H. Caldwell Understanding Why Patients Delay Seeking Care for Acute Coronary Syndromes Circ Cardiovasc Qual Outcomes, May 1, 2009; 2(3): 148 - 154. [Abstract] [Full Text] [PDF]

				E. R. Bates and B. K. Nallamothu Commentary: The Role of Percutaneous Coronary Intervention in ST-Segment-Elevation Myocardial Infarction Circulation, July 29, 2008; 118(5): 567 - 573. [Full Text] [PDF]

				K. Dracup, S. McKinley, L. V. Doering, B. Riegel, H. Meischke, D. K. Moser, M. Pelter, B. Carlson, L. Aitken, A. Marshall, et al. Acute Coronary Syndrome: What Do Patients Know? Arch Intern Med, May 26, 2008; 168(10): 1049 - 1054. [Abstract] [Full Text] [PDF]

				E. R. Bates Role of Intravenous -Blockers in the Treatment of ST-Elevation Myocardial Infarction: Of Mice (Dogs, Pigs) and Men Circulation, June 12, 2007; 115(23): 2904 - 2906. [Full Text] [PDF]

				S. Noureddine, M. Adra, M. Arevian, N. Y. Dumit, H. Puzantian, D. Shehab, and A. Abchee Delay in Seeking Health Care for Acute Coronary Syndromes in a Lebanese Sample J Transcult Nurs, October 1, 2006; 17(4): 341 - 348. [Abstract] [PDF]

				A. Schomig, G. Ndrepepa, and A. Kastrati Late myocardial salvage: time to recognize its reality in the reperfusion therapy of acute myocardial infarction Eur. Heart J., August 2, 2006; 27(16): 1900 - 1907. [Abstract] [Full Text] [PDF]

				D. K. Moser, L. P. Kimble, M. J. Alberts, A. Alonzo, J. B. Croft, K. Dracup, K. R. Evenson, A. S. Go, M. M. Hand, R. U. Kothari, et al. Reducing Delay in Seeking Treatment by Patients With Acute Coronary Syndrome and Stroke: A Scientific Statement From the American Heart Association Council on Cardiovascular Nursing and Stroke Council Circulation, July 11, 2006; 114(2): 168 - 182. [Abstract] [Full Text] [PDF]

				R. T. van Domburg, K. Sonnenschein, R. Nieuwlaat, O. Kamp, C. J. Storm, J. J. Bax, and M. L. Simoons Sustained Benefit 20 Years After Reperfusion Therapy in Acute Myocardial Infarction J. Am. Coll. Cardiol., July 5, 2005; 46(1): 15 - 20. [Abstract] [Full Text] [PDF]

				P. J de Kam, A. A Voors, F. Fici, D. J van Veldhuisen, and W. H van Gilst Review: The revised role of ACE-inhibition after myocardial infarction in the thrombolytic/primary PCI era Journal of Renin-Angiotensin-Aldosterone System, December 1, 2004; 5(4): 161 - 168. [Abstract] [PDF]

				R. A. Kloner and S. H. Rezkalla Cardiac protection during acute myocardial infarction: Where do we stand in 2004? J. Am. Coll. Cardiol., July 21, 2004; 44(2): 276 - 286. [Abstract] [Full Text] [PDF]

				M. T Dirksen, G. Laarman, A. W.J van 't Hof, G. Guagliumi, W. A.L Tonino, L. Tavazzi, D. J.G.M Duncker, M. L Simoons, and on behalf of the PARI-MI Investigators The effect of ITF-1697 on reperfusion in patients undergoing primary angioplasty: Safety and efficacy of a novel tetrapeptide, ITF-1697 Eur. Heart J., March 1, 2004; 25(5): 392 - 400. [Abstract] [Full Text] [PDF]

				A.S Petronio, D Rovai, G Musumeci, R Baglini, C Nardi, U Limbruno, C Palagi, D Volterrani, and M Mariani Effects of abciximab on microvascular integrity and left ventricular functional recovery in patients with acute infarction treated by primary coronary angioplasty Eur. Heart J., January 1, 2003; 24(1): 67 - 76. [Abstract] [Full Text] [PDF]

				M.L. Simoons, M. Krzeminska-Pakula, A. Alonso, S.G. Goodman, A. Kali, U. Loos, F. Gosset, V. Louer, and F. Bigonzi Improved reperfusion and clinical outcome with enoxaparin as an adjunct to streptokinase thrombolysis in acute myocardial infarction. The AMI-SK study Eur. Heart J., August 2, 2002; 23(16): 1282 - 1290. [Abstract] [PDF]

				H. Mickley and S. Gill Is time the overriding factor in thrombolytic therapy? Eur. Heart J., March 1, 2002; 23(5): 347 - 349. [Full Text] [PDF]

				D. Scrutinio, C. Cimminiello, E. Marubini, M. Vittoria Pitzalis, M. Di Biase, P. Rizzon, and the STAMI Group Ticlopidine versus aspirin after myocardial infarction (stami) trial J. Am. Coll. Cardiol., April 1, 2001; 37(5): 1259 - 1265. [Abstract] [Full Text] [PDF]

				J. W. Kennedy Thrombolytic therapy in acute myocardial infarction J. Am. Coll. Cardiol., April 1, 2000; 35(5_Suppl_B): 25B - 28B. [PDF]

				J. Sztajzel, F. Mach, and A. Righetti Current concepts in medicine: Role of the vascular endothelium in patients with angina pectoris or acute myocardial infarction with normal coronary arteries Postgrad. Med. J., January 1, 2000; 76(891): 16 - 21. [Abstract] [Full Text]

				F. Zijlstra, J. C.A. Hoorntje, M.-J. de Boer, S. Reiffers, K. Miedema, J. P. Ottervanger, A. W.J. van 't Hof, and H. Suryapranata Long-Term Benefit of Primary Angioplasty as Compared with Thrombolytic Therapy for Acute Myocardial Infarction N. Engl. J. Med., November 4, 1999; 341(19): 1413 - 1419. [Abstract] [Full Text] [PDF]

				A. van der Laarse Rapid estimation of myocardial infarct size Cardiovasc Res, November 1, 1999; 44(2): 247 - 248. [Full Text] [PDF]

				F Vermeer, A J M O. Ophuis, E J v. Berg, L G Brunninkhuis, C J Werter, A G Boehmer, A H Lousberg, W R Dassen, and F W Bar Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study Heart, October 1, 1999; 82(4): 426 - 431. [Abstract] [Full Text] [PDF]

				J. W. Kennedy Thrombolytic therapy in acute myocardial infarction J. Am. Coll. Cardiol., June 1, 1999; 33(7): 1829 - 1832. [Abstract] [Full Text] [PDF]

				M Faraggi, G Montalescot, L Sarda, J F Heintz, D Doumit, G Drobinski, I Sotirov, D Le Guludec, and D Thomas Spontaneous late improvement of myocardial viability in the chronic infarct zone is possible, depending on persistent TIMI 3 flow and a low grade stenosis of the infarct artery Heart, April 1, 1999; 81(4): 424 - 430. [Abstract] [Full Text]

				M. Previtali, R. Fetiveau, L. Lanzarini, C. Cavalotti, and C. Klersy Prognostic value of myocardial viability and ischemia detected by dobutamine stress echocardiography early after acute myocardial infarction treated with thrombolysis J. Am. Coll. Cardiol., August 1, 1998; 32(2): 380 - 386. [Abstract] [Full Text] [PDF]

				O. Gurevitz, A. Goldfarb, H. Hod, M. Feldman, B. Shenkman, D. Varon, M. Eldar, and A. Inbal Recombinant von Willebrand Factor Fragment AR545C Inhibits Platelet Aggregation and Enhances Thrombolysis With rtPA in a Rabbit Thrombosis Model Arterioscler Thromb Vasc Biol, February 1, 1998; 18(2): 200 - 207. [Abstract] [Full Text] [PDF]

				M. H. Raitt, C. Maynard, G. S. Wagner, M. D. Cerqueira, R. H. Selvester, and W. D. Weaver Relation Between Symptom Duration Before Thrombolytic Therapy and Final Myocardial Infarct Size Circulation, January 1, 1996; 93(1): 48 - 53. [Abstract] [Full Text]

				J.A. Prieto-Solis, J. Domenech, J.M. San Jose, M.A. Villalobos, and F. Jimeno Electrocardiographic Diagnosis of the Responsible Coronary Artery in Acute Inferior Myocardial Infarction Through Right Chest Leads V3R-V8R: A Prospective Study Angiology, November 1, 1995; 46(11): 989 - 998. [Abstract] [PDF]

				E. T. Hasche, C. Fernandes, S. B. Freedman, and R. W. Jeremy Relation Between Ischemia Time, Infarct Size, and Left Ventricular Function in Humans Circulation, August 15, 1995; 92(4): 710 - 719. [Abstract] [Full Text]

				R.J. Simes, E. J. Topol, D. R. Holmes Jr, H. D. White, W. R. Rutsch, A. Vahanian, M. L. Simoons, D. Morris, A. Betriu, R. M. Califf, et al. Link Between the Angiographic Substudy and Mortality Outcomes in a Large Randomized Trial of Myocardial Reperfusion : Importance of Early and Complete Infarct Artery Reperfusion Circulation, April 1, 1995; 91(7): 1923 - 1928. [Abstract] [Full Text]

				A. M. Fendrick, P. M. Ridker, and B. S. Bloom Improved Health Benefits of Increased Use of Thrombolytic Therapy Arch Intern Med, July 25, 1994; 154(14): 1605 - 1609. [Abstract] [PDF]

				C. L. Grines, K. F. Browne, J. Marco, D. Rothbaum, G. W. Stone, J. O'Keefe, P. Overlie, B. Donohue, N. Chelliah, G. C. Timmis, et al. A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction N. Engl. J. Med., March 11, 1993; 328(10): 673 - 679. [Abstract] [Full Text]

				F. Zijlstra, M. J. de Boer, J. Hoorntje, S. Reiffers, J. Reiber, and H. Suryapranata A Comparison of Immediate Coronary Angioplasty with Intravenous Streptokinase in Acute Myocardial Infarction N. Engl. J. Med., March 11, 1993; 328(10): 680 - 684. [Abstract] [Full Text]

				R. J. Gibbons, D. R. Holmes, G. S. Reeder, K. R. Bailey, M. R. Hopfenspirger, B. J. Gersh, and The Mayo Coronary Care Unit and Catheterization La Immediate Angioplasty Compared with the Administration of a Thrombolytic Agent Followed by Conservative Treatment for Myocardial Infarction N. Engl. J. Med., March 11, 1993; 328(10): 685 - 691. [Abstract] [Full Text]

				N. Hamouratidis, N. Katsaliakis, F. Manoudis, K. Lazaridis, T. Tselegaridis, V. Stravelas, E. Simeonidou, and S. Roussis Early Exercise Test in Acute Myocardial Infarction Treated with Intravenous Streptokinase Angiology, September 1, 1991; 42(9): 696 - 702. [Abstract] [PDF]

				S. Sherry and V. J. Marder Streptokinase and Recombinant Tissue Plasminogen Activator (rt-PA) Are Equally Effective in Treating Acute Myocardial Infarction Ann Intern Med, March 1, 1991; 114(5): 417 - 423. [Abstract] [PDF]

				T. F. Christian, I. P. Clements, T. Behrenbeck, K. C. Huber, J. H. Chesebro, B. J. Gersh, and R. J. Gibbons Limitations of the Electrocardiogram in Estimating Infarction Size after Acute Reperfusion Therapy for Myocardial Infarction Ann Intern Med, February 15, 1991; 114(4): 264 - 270. [Abstract] [PDF]

				T. H. Lee, M. C. Weisberg, D. A. Brand, G. W. Rouan, and L. Goldman Candidates for Thrombolysis among Emergency Room Patients with Acute Chest Pain: Potential True- and False-Positive Rates Ann Intern Med, June 15, 1989; 110(12): 957 - 962. [Abstract] [PDF]

				E Haber, T Quertermous, G. Matsueda, and M. Runge Innovative approaches to plasminogen activator therapy Science, January 6, 1989; 243(4887): 51 - 56. [Abstract] [PDF]